马志国

发布者：2017-09-26发布者：31

  • 1、Pharmaceutical Dispersion Techniques for Dissolution and Bioavailability Enhancement of Poorly Water-Soluble Drugs,PHARMACEUTICS,2018.09.01 00:00:00,马志国,550,4
  • 2、Selenium-functionalized liposomes for systemic delivery of doxorubicin with enhanced pharmacokinetics and anticancer effect,EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS,2018.01.01 00:00:00,马志国,550,5
  • 3、药学实验教学示范中心建设与实践,实验室研究与探索,2018.10.15 00:00:00,马志国,550,1
  • 4、学研式教学法用于中药炮制学教学的体会,中医药管理杂志,2018.08.14 00:00:00,马志国,550,1
  • 5、肉苁蓉加工炮制现代研究进展,海峡药学,2018.01.01 00:00:00,马志国,550,7
  • 6、Structure-based drug design of catechol-O-methyltransferase inhibitors for CNS disorders BRITISH JOURNAL OF CLINICAL PHARMACOLOGY,BRITISH JOURNAL OF CLINICAL PHARMACOLOGY,2014.03.01 00:00:00,???,550,1
  • 7、Structure-activity relationships and in silico models of P-glycoprotein (ABCB1) inhibitors XENOBIOTICA,XENOBIOTICA,SCI,2013.11.01 00:00:00,马志国,550,2
  • 8、Arylamine N-acetyltransferases: a structural perspective BRITISH JOURNAL OF PHARMACOLOGY,BRITISH JOURNAL OF PHARMACOLOGY,SCI,2013.06.01 00:00:00,马志国,550,2
  • 9、Effects of PEGylated lipid nanoparticles on the oral absorption of one BCS II drug: a mechanistic investigation INTERNATIONAL JOURNAL OF NANOMEDICINE,INTERNATIONAL JOURNAL OF NANOMEDICINE,2014.01.01 00:00:00,马志国,550,4
  • 10、Effects of pharmaceutical PEGylation on drug metabolism and its clinical concerns EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY,EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY,2014.12.01 00:00:00,马志国,550,3
  • 11、Metabolism of the anthelmintic drug niclosamide by cytochrome P450 enzymes and UDP-glucuronosyltransferases: metabolite elucidation and main contributions from CYP1A2 and UGT1A1 XENOBIOTICA,XENOBIOTICA,2016.01.02 00:00:00,马志国,550,2
  • 12、Enhancement of Oral Bioavailability of Tripterine Through Lipid Nanospheres: Preparation, Characterization, and Absorption Evaluation JOURNAL OF PHARMACEUTICAL SCIENCES,JOURNAL OF PHARMACEUTICAL SCIENCES,2014.06.01 00:00:00,马志国,550,6
  • 13、Nanostructured lipid carriers used for oral delivery of oridonin: An effect of ligand modification on absorption INTERNATIONAL JOURNAL OF PHARMACEUTICS,INTERNATIONAL JOURNAL OF PHARMACEUTICS,2015.02.20 00:00:00,马志国,550,6
  • 14、Selenium nanoparticles as versatile carriers for oral delivery of insulin: Insight into the synergic antidiabetic effect and mechanism,Nanomedicine: Nanotechnology, Biology, and Medicine,2017.08.01 00:00:00,马志国,540,4
  • 15、Stable Knock-down of Efflux Transporters Leads to Reduced Glucuronidation in,UGT1A1-Overexpressing He La Cells: The Evidence for Glucuronidation-Transport Interplay MOLECULAR PHARMACEUTICS,MOLECULAR PHARMACEUTICS,2015.04.01 00:00:00,马志国,550,4
  • 16、Phospholipid-stabilized mesoporous carbon nanospheres as versatile carriers for systemic delivery of amphiphobic SNX-2112 (a Hsp90 inhibitor) with enhanced antitumor effect EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS,EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS,2015.08.01 00:00:00,马志国,550,7
  • 17、Selenium nanoparticles as versatile carriers for oral delivery of insulin: Insight into the synergic antidiabetic effect and mechanism NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE,NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE,2017.08.01 00:00:00,马志国,540,4
  • 18、Establishment of pharmacophore and VolSurf models to predict the substrates of UDP-glucuronosyltransferase1A3 XENOBIOTICA,XENOBIOTICA,2015.08.01 00:00:00,马志国,540,3
  • 19、Identification of glucuronidation and biliary excretion as the main mechanisms for gossypol clearance: in vivo and in vitro evidence XENOBIOTICA,XENOBIOTICA,2014.08.01 00:00:00,马志国,580,6
  • 20、Establishment of pharmacophore and VolSurf models to predict the substrates of UDP-glucuronosyltransferase1A3,XENOBIOTICA,2015.08.01 00:00:00,马志国,540,3
  • 21、Phospholipid-stabilized mesoporous carbon nanospheres as versatile carriers for systemic delivery of amphiphobic SNX-2112 (a Hsp90 inhibitor) with enhanced antitumor effect,EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS,2015.08.01 00:00:00,马志国,550,7
  • 22、Metabolism of the anthelmintic drug niclosamide by cytochrome P450 enzymes and UDP-glucuronosyltransferases: metabolite elucidation and main contributions from CYP1A2 and UGT1A1,XENOBIOTICA,2016.01.02 00:00:00,马志国,550,2
  • 23、Identification of glucuronidation and biliary excretion as the main mechanisms for gossypol clearance: in vivo and in vitro evidence,XENOBIOTICA,2014.08.01 00:00:00,马志国,580,6
  • 24、Effects of PEGylated lipid nanoparticles on the oral absorption of one BCS II drug: a mechanistic investigation,INTERNATIONAL JOURNAL OF NANOMEDICINE,2014.01.01 00:00:00,马志国,550,4